In Vitro Effect of Vancomycin on the Viability of Articular Chondrocytes

K Aaron Shaw1, Josef K Eichinger2, Nischal Nadig1

  • 1Department of Orthopaedic Surgery, Dwight D. Eisenhower Army Medical Center, Fort Gordon, GA.

Abstract

Insights

Vancomycin shows toxicity to articular cartilage chondrocytes at concentrations of 5 mg/mL and higher. Further research is needed to control vancomycin concentrations before its use in synovial joints.

Area of Science:

  • Biomedical Science
  • Orthopedics
  • Pharmacology

Background:

  • Articular cartilage is vital for joint function.
  • Topical antibiotics are increasingly used in orthopedic surgery.
  • Understanding vancomycin's effect on cartilage is crucial for patient safety.

Purpose of the Study:

  • To investigate the in vitro toxicity of vancomycin on articular cartilage chondrocytes.
  • To determine the dose-dependent effects of vancomycin on chondrocyte viability.

Main Methods:

  • Osteochondral samples from porcine stifle joints were used.
  • Samples were exposed to varying concentrations of vancomycin (2, 5, 10 mg/mL).
  • Chondrocyte viability was assessed using histology (Mankin criteria) and live/dead staining.

Main Results:

  • No significant difference in chondrocyte viability at 2 mg/mL vancomycin compared to controls.
  • Statistically significant chondrocyte toxicity observed at 5 mg/mL and 10 mg/mL vancomycin.
  • Vancomycin demonstrated a dose-dependent toxicity to chondrocytes.

Conclusions:

  • Vancomycin is toxic to articular chondrocytes at concentrations of 5 mg/mL and above.
  • Concentration control strategies are necessary for safe topical vancomycin application around synovial joints.

Related Concept Videos